Biotech Week articles from October 2004

Biotech Week archives from October 2004

FDA approval sought for AbioCor replacement heart.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abiomed, Inc., (ABMD) announced that the company has submitted, pending acceptance for filing, to the U.S. Food and Drug Administration (FDA) for market approval the AbioCor Implantable Replacement...

FDA approves Methylin Chewable Tablets, Methylin Oral Solution for ADHD.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Alliant Pharmaceuticals, Inc., announced U.S. Food and Drug Administration (FDA) approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the...

Crestor reaches 10M prescription milestone.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that Crestor (rosuvastatin), its statin indicated for the treatment of dyslipidemia, has reached the significant milestone of 10 million prescriptions worldwide. Crestor is...

Wireless care improves monitoring of elderly and disabled people.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- In the past, old age or disabilities have often implied a loss of independence, as elderly and disabled people find themselves reliant on family members and carers to look after them. That situation may...

Excess GM1-ganglioside in brain cells triggers neurodegeneration, retardation.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Excess accumulation in brain cells of a fat molecule called GM1-ganglioside (GM1) disrupts the folding of newly assembled proteins into their proper shapes, triggering nerve degeneration and mental...

Consistency of treatment for external genital warts is variable in the U.K.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The consistency of treatment for external genital warts is variable in the United Kingdom. According to recent research from the United States, "Our objective was to identify patterns of treatment...

Additional drug discovery deal with Synaptic signed.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- 7TM Pharma announced that 7TM Pharma and Synaptic, a wholly owned subsidiary of Lundbeck, have signed a new collaborative research agreement again focused on 7TM Pharma's drug discovery approach. ...

First lady of Zambia dedicates new AIDS treatment clinic in Chikankata, Zambia.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Mrs. Maureen Mwanawasa, the first lady of Zambia, officially launched and dedicated the Salvation Army-AIDS Healthcare Foundation-Global Immunity Muka Buumi ("Mother of Life" in Tonga) anti-retroviral...

Nutritional supplements company reports a 34% increase in customers.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AMS Health Sciences, Inc., (AMM, AMS) announced August month-end results of its new customer acquisition program, totaling 8751 new associates and preferred customers, averaging $60 per monthly...

Enteroviral meningitis outbreak in France is caused by human echovirus 30.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- An enteroviral meningitis outbreak in France is caused by human echovirus 30. According to recent research from France, "Enteroviruses (EVs) are responsible for an array of clinical diseases...

Pharmaceutical firm secures seed funding of $1.6M.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- APT Therapeutics, Inc., announced that it has recently secured seed funding of $1.6 million from two venture capital firms: Prolog Ventures (St. Louis) and CID Equity Partners (Indianapolis). With...

Paper describes new treatment for prevention of postsurgical adhesions.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., announced that Dr. Johanne Cashman, director of preclinical research, published a paper entitled "Camptothecin-loaded Films for the Prevention of Postsurgical Adhesions" in...

ELVIS plate method is effective in detecting and typing herpes simplex.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Study finds that a commercial enzyme-linked viral inducible system (ELVIS) is a reliable alternative to shell vial culture (SVC) for rapid detection and typing of herpes simplex virus (HSV). "This...

Antisense approach to transplant acceptance works by regulating lymphocytes.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced that it presented data on its Neugene antisense approach to transplant acceptance at the 20th International Congress of the Transplantation Society, held in Vienna,...

Freestyle Mini, Precision Xceed blood glucose monitors launched in Europe.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories introduced the FreeStyle Mini and Precision Xceed blood glucose monitoring systems for Europe at the 40th Annual Meeting of the European Association for the Study of Diabetes in...

Fully automated test for Hepatitis A virus released.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories introduced its second fully automated hepatitis A test in the United States for its widely used AxSYM automated immunoassay instrument system. Used to aid in the laboratory...

Pharmaceutical firm appoints H. Ward Wolff as chief financial officer.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc., (ABGX) announced the appointment of H. Ward Wolff as chief financial officer and Senior VP, Finance, effective September 13. "Ward brings more than 25 years of finance, operating and...

Generic pharmaceutical firm announces management appointments.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX) announced the appointments of Joan Janulis - VP, regulatory affairs, and Janet E. Penner - VP, sales and marketing. Janulis has more than 17 years of experience in...

Prize for modern nutrition from the Federation of Swiss Milk Producers awarded.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Dr. David McCarron, president of Academic Network LLC and visiting professor at the Department of Nutrition at University California Davis, was awarded the 2004 International Prize for Modern Nutrition...

Genetics of variations of Yersinia pestis biovars presented.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers report the genetics of metabolic variations between Yersinia pestis biovars and propose a new biovar, microtus. "Yersinia pestis has been historically divided into three biovars:...

Study shows ACP-103 improves clinical profile of haloperidol treatment.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals, Inc., (ACAD), a biopharmaceutical company utilizing innovative science to fuel drug discovery and clinical development of novel treatments for central nervous system disorders,...

Life sciences IT firm appoints new VP of marketing.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, Inc., (ACCL) announced that R. William (Bill) Taylor joined the company as vice president, marketing. Taylor brings more than 20 years of experience in the high-technology field,...

Pharmaceutical firm to license Accelrys software.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Accelrys, Inc., (ACCL) announced an agreement with Bayer Healthcare AG under which Bayer has licensed a comprehensive library of life science modeling software from Accelrys. These tools, which...

Pharmaceutical firm reports best year ever for sales, profits.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aceto Corporation (ACET), a global distributor of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and agrochemicals, announced record results of operations for the fourth...

Pharmaceutical firm reports fourth quarter net income up 36%.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aceto Corporation (ACET) announced record results of operations for the fourth quarter and fiscal year ended June 30, 2004. Fourth quarter financial highlights include: 1) net sales grew 12% to...

Pharmaceutical firm elects Sandra Fenwick to board of directors.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Acusphere, Inc., (ACUS), a specialty pharmaceutical company that develops drug products using its proprietary porous microparticle technology, announced that Sandra L. Fenwick has been elected to the...

Oncology company names chief medical officer.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Adherex Technologies, Inc., (AHX), a biopharmaceutical company with a broad portfolio of clinical oncology products under development, announced that Rajesh K. Malik has joined the company as its chief...

FDA accepts Entereg (alvimopan) NDA for review.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Adolor Corp. (ADLR) and GlaxoSmithKline (GSK) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the new drug application (NDA) for Entereg (alvimopan) capsules. ...

Medical device company named to list of 100 fastest-growing companies.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Neuromodulation Systems, Inc., (ANS, ANSI) was recently ranked 22nd on Fortune magazine's 16th annual list of 100 Fastest-Growing Companies. "ANS is honored to appear on such a prestigious...

FDA conditional approval granted to use Petal Stent System in BOSS trial.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Stent Technologies (AST), Inc., received U.S. Food & Drug Administration (FDA) conditional approval to incorporate its bare metal novel Petal coronary bifurcation stent and delivery system into...

Successful pre-IND meeting for AVR118 with FDA reported.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company had a successful pre-investigational new drug (IND) meeting with the U.S. Food & Drug Administration (FDA) at the end of August. ...

Biopharmaceutical firm board of directors appoints Evan Levine president, CEO.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals, Inc., (ANX) announced that the board of directors appointed Evan M. Levine to serve as president and CEO effective September 4, 2004, to fill the place of Nicholas J. Virca who...

IND allowed for ALS treatment.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aeolus Pharmaceuticals, Inc., (AOLS) announced that it has been notified by the U.S. Food and Drug Administration (FDA) of their allowance of Aeolus' Investigational New Drug application (IND) to begin...

Hand-held device measures airway inflammation.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Clinical data on a new first-of-a-kind hand-held analyser of inflammation in asthma patients, Niox Mino, were presented for the first time on September 5, 2004, at the European Respiratory Society (ERS)...

New linear RNA amplification protocol works with very small samples.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Affymetrix Inc.'s high-density oligonucleotide microarray analysis protocol that includes a linear amplification step has use in situations where RNA recovery is very low, pathologists report. ...

Non-sexual household exposures spawn hepatitis C virus clusters in Pakistan.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Non-sexual household exposures spawn hepatitis C virus clusters in Pakistan. According to recent research from Pakistan, "transmission rates of hepatitis C virus (HCV) infection through non-sexual...

Genomics company expands, relocates to new facility.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, celebrated the grand opening of its new corporate headquarters in...

PUVA therapy-induced lentigine development reported.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Extensive psoralen plus ultraviolet A (PUVA) irradiation therapy may induce lentigine development in vitiligo patients. PUVA therapy is "commonly used for the management of vitiligo, in which...

Rat study suggests L-leucine, taken orally during pregnancy, doesn't harm fetus.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A study conducted in pregnant rats indicates that L-leucine, taken orally, doesn't affect pregnancy outcome and doesn't harm the fetus. "L-Leucine, an essential amino acid, is one of the most...

Tumor-specific gene therapy targets uterine cervical cancer.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Tumor-specific gene therapy targets uterine cervical cancer. According to published research from South Korea, "although gene therapies using tissue-specific promoters have been reported to be a...

Agent-based analysis of smallpox preparedness performed.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Researchers have performed an agent-based analysis of smallpox preparedness and response policy. According to recent research published in the JASSS - the Journal of Artificial Societies and Social...

Shiga toxin 1-neutralizing Fab fragment isolated.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A Shiga toxin (Stx)-neutralizing Fab fragment has been isolated and characterized. Stx-producing E. coli (STEC) "causes bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome,"...

Pharmaceutical firm names new VP, global quality and regulatory compliance.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (AKRN.OB) announced the appointment of Marshall L. Goodwin as VP, Global Quality and Regulatory Compliance. Goodwin has more than 25 years of quality assurance and operations...

Calcium-free products bind phosphate without cardiovascular calcification.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A new report describes the challenges and trends in calcium and phosphorus management in chronic kidney disease. According to the report from the United States, "Common and serious comorbidities in...

DNA binding to viral enzyme may serve as new target for antiviral drugs.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and the Albert Einstein College of Medicine have produced the first molecular-scale images of DNA binding to an adenovirus...

Hypothalamic responses to long-chain fatty acids are nutritionally regulated.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Hypothalamic responses to long-chain fatty acids are nutritionally regulated. According to recent research from the United States, "Central administration of the long-chain fatty acid oleic acid...

Linkage between chromosome 21q22 and bipolar disorder points to allele 2.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Linkage between chromosome 21q22 and bipolar disorder points to allele 2. "Linkage analysis has shown that chromosome 21q22 may contain a candidate gene for bipolar disorder (BPD). One potential...

Biotech firm's shares to trade on NASDAQ SmallCap market.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Alfacell Corporation (ACEL), a biopharmaceutical company focused on the discovery, development and commercialization of ribonucleases for anti-cancer and other therapeutic applications, announced that...

Antisense repression of p53 raises cancer cell chemosensitivity.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Antisense repression of p53 raises cancer cell chemosensitivity. "Most gene therapy strategies related to p53 concentrate on the restoration of the activity of mutant p53, as several observations...

Research shows almonds increase intake of several important nutrients.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- According to researchers at Loma Linda University in California, when individuals added almonds as a snack to their regular diet, their overall intake of several important nutrients increased. The...

TheraCLEC selected for FDA's Continuous Marketing Application Pilot 2 program.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Altus Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has selected TheraCLEC for participation in the Continuous...

Group applauds House passage of memory screening proposal.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The Alzheimer's Foundation of America (AFA) applauded passage by the U.S. House of Representatives of a proposal advanced by AFA to promote memory screenings as a tool that drives early diagnosis and...

Request submitted to FDA for designated new animal drug listing.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc., (AMAR) announced that it has submitted requests to the U.S. Food & Drug Administration's (FDA) Office of Minor Use and Minor Species Animal Drug Development (MUMS) for...

Update given on ICS technology development.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Sydney-based Ambri Limited (ABI) announced that its international strategic alliance partner Biosensor Enterprises LLC (BEL), a joint venture of Dow Corning Corporation and Genencor International, has...

Acquisition of Chinese state-owned pharmaceutical company completed.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- America Oriental Bioengineering, Inc., (AOBO) announced the successful completion of its acquisition of Heilongjiang Songhuajiang Pharmaceutical Limited (HSPL), a Chinese state-owned pharmaceutical...

Hazards of surgery and anesthesia for drug, alcohol abusers presented at meeting.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Substance abusers who think it's okay not to tell their oral and maxillofacial surgeon about their drug use are putting themselves at risk for surgical complications, even if they're having a procedure...

Guidelines offer new recommendations for travelers.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- New antithrombotic guidelines from the American College of Chest Physicians (ACCP) introduce novel therapies for the prevention and treatment of thrombosis and, for the first time, offer specific...

Outline provided for developing national clinical trials registry.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- For the first time since announcing its support of a national clinical trials registry, the American Medical Association outlined to Congress key criteria needed to make such a registry effective. ...

Pharmaceutical company obtains an unsecured $100M credit facility.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX) announced that it has established a $100 million unsecured, 3-year, senior revolving credit facility. The new facility, expandable to $150 million,...

Excimer lasers safe, effective for pediatric eye maladies, study shows.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The first study to document the safety and effectiveness of the use of excimer lasers to treat a variety of eye maladies in children was published in the September edition of the Journal of Cataract &...

New statement published on nonmalignant diseases related to asbestos exposure.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- In its first official statement since 1986 on the topic, the American Thoracic Society (ATS) has published a document entitled Diagnosis and Initial Management of Nonmalignant Diseases Related to...

HGV transmitted efficiently via the sexual route.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Hepatitis G virus is transmitted efficiently via the sexual route. According to a study from Lebanon, "The importance of sexual transmission in the epidemiology of hepatitis G virus (HGV) and...

Biotech demerger completed, key appointments reported.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Amrad Corporation Limited (AML) announced successful completion of the final steps in the demerger and spin-out of its anti-infectives business, Avexa Limited. Having obtained shareholder approval...

Pharmaceutical companies sign drug discovery deal.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Anadys Pharmaceuticals, Inc., (ANDS) and Aphoenix, Inc., an emerging chemical genomics company in Japan, announced that they have entered into a 3-year drug discovery collaboration. Under the terms...

Device company forms scientific advisory board.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Andromed, Inc., (AD) has formed a scientific advisory board consisting of four clinicians: Richard Hughes, Joseph V. Messer, Edward S. Ogata and Hans Pasterkamp. This high-caliber scientific...

Pharmaceutical firm reports on meeting with FDA about manufacturing facilities.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that it recently met with representatives of the regional office of the U.S. Food and Drug Administration (FDA) to discuss the inspectional observations reflected in...

Health Canada approves Animas IR 1200 insulin pump for distribution.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Animas Corporation (PUMP) announced that Health Canada has approved the distribution of the Animas IR 1200 insulin pump in Canada. The IR 1200 pump received approval from the U.S. Food and Drug...

Alastair Wood joins immunotherapeutics company board of directors.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced the appointment of Alastair J. J. Wood, MD, to its board of directors. Wood, a 2002 nominee for commissioner of the U.S. Food and Drug Administration (FDA),...

GTG reports on the current status of legal action to protect its patents.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Genetic Technologies, Ltd., (GNTLY) previously reported to the market it was pursuing legal action in the U.S. against Applera Corp. for patent infringement of the GTG noncoding patents. In...

Financing agreement signed with HiProtech International.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aquagen International, Inc., a manufacturer and distributor of premier oxygen supplement products, announced that it has signed an agreement with HiProtech International, Inc., an independent financing...

New York Visiting Nurse Association awards wireless messaging contract.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Aquis Communications Group, Inc. (AQIS), a wireless company, has been awarded a contract to provide wireless communications services to the Visiting Nurse Association of Long Island, Inc., located in...

British pharma firm closes GBP29M third round financing.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Arakis, Ltd., announced the successful completion of a GBP29 million third round financing, jointly led by Novo A/S and Scottish Equity Partners, Ltd. The financing will enable the company to...

Medical laser manufacturer announces new company president.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Archer Medical Technologies, Inc., (ARHT) announced that current executive VP, Paul Tibbets, assumed the duties and role of president effective Sept. 1, 2004. After graduating from Texas Tech...

Novel therapy has positive effect on lipid uptake in cystic fibrosis patients.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Arexis AB announced the completion of a successful phase II clinical trial around their novel human enzyme replacement therapy for the treatment of fat mal-absorption in patients with cystic fibrosis....

Instrument maker announces new headquarters.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Argonaut Technologies (AGNT), a provider of chemistry instruments and consumables to help the pharmaceutical industry accelerate drug development, announced the relocation of its corporate headquarters...

HIV vaccine combination safe and immunogenic in HIV-negative adults.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- An HIV subtype B and E prime-boost vaccine combination was safe and immunogenic in HIV-negative Thai adults. "ALVAC-HIV (vCP1521) and AIDSVAX B/E were evaluated in a phase 1/2 trial of human...

Biopharmaceutical firm announces new management, board members.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Arriva Pharmaceuticals, Inc., announced four key additions to the company's management team and board of directors. The new appointments will support Arriva's activities as the company registers...

Device company acquires soft tissue repair technology company.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- ArthroCare Corp. (ARTC), a multi-business medical device company that develops minimally invasive surgical products, announced that it has reached a definitive agreement to acquire Opus Medical, a maker...

Oxygen-regulated protein 150 protects renal cells from injury.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Oxygen-regulated protein 150 protects renal cells from injury. According to published research from Japan, "the 150 kDa oxygen-regulated protein (ORP150) is an inducible endoplasmic reticulum (ER)...

Purified protein maker completes $2,535,000 private placement.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- AspenBio, Inc., (APNB) announced that it has completed and terminated its offering under a private placement of unregistered securities totaling an aggregate of $2,535,000, with $1,247,500, having...

Clinton was a "vulnerable patient".
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The Association for Eradication of Heart Attack (AEHA) said that the case of former president Bill Clinton illustrates the serious gap that exists between the scientific understanding of heart attack...

CRO group establishes global influence with Input to EMEA.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The Association of Clinical Research Organizations (ACRO), representing companies that are key participants in the clinical development of new medicinal products, is consulting regularly with European...

Oral surgeons explore anesthesia care for complex patients at conference.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- The biggest challenge facing the oral and maxillofacial surgeon isn't the surgery, it's the anesthesia. With demographic changes and shifting disease patterns, OMSs have begun seeing unprecedented...

Medical schools tighten conflict-of-interest standards.
October 6, 2004... 2004 OCT 6 - (NewsRx.com & NewsRx.net) -- A recent study by the Association of American Medical Colleges (AAMC) indicates that U.S. medical schools have made significant progress since 2001 in clarifying and strengthening their financial...